Industry News
Medtech zinc sensor uses the power of light
Australian researchers have designed a chemical sensor that can detect and measure zinc levels in cells, allowing for a deeper understanding of the dynamic roles that metal ions play in the human body. [ + ]
New board members elected to Science & Technology Australia
Science & Technology Australia (STA) has elected three new leaders in science, technology, engineering and mathematics (STEM) to its board, in an effort to represent scientists and technologists working in a range of disciplines. [ + ]
Novel drug combo for triple-negative breast cancer
In the hunt for novel treatments against triple-negative breast cancer, US researchers have combined a new protein inhibitor with a chemotherapy drug. [ + ]
New gene circuit design strategy to advance synthetic biology
US researchers have developed an approach to gene circuit design that is far more efficient than current techniques. [ + ]
Arrow Scientific merges with Key Diagnostics
Food testing company Arrow Scientific has announced that it is merging with Key Diagnostics, effective as of 1 October. [ + ]
Dual-action cancer treatment supercharges immune cells
Western Australian researchers have developed a new cancer treatment with the dual ability to normalise tumour blood vessels and boost the body's immune system. [ + ]
Automated image analysis to aid bladder cancer diagnosis
Australian researchers have developed an automated computer technique that is able to aid in the diagnosis of bladder cancer, allowing suspect lesion images to be quickly and effectively analysed and then classified for cancer risk. [ + ]
Sequencing the yam genome to improve food security
An international research collaboration has provided a genome sequence for the white Guinea yam — a staple crop with huge economic and cultural significance on the African continent. [ + ]
Antibiotic resistance is endemic, not an epidemic — UNSW study
According to a new study from UNSW, antimicrobial resistance (AMR) is not itself an epidemic. Rather, it has the potential to worsen pandemics or seasonal influenza epidemics, and should be kept in perspective. [ + ]
Synthetic molecule directs stem cells to turn into heart muscle cells
Stem cells can now be triggered to change into heart muscle cells thanks to a new method involving synthetic molecules, developed by researchers at Kyoto University. [ + ]
Single-cell sequencing system tackles kidney research
Monash University scientists have adopted a Single Cell RNA-Seq System, from Dolomite Bio, to further their research into animal models of diabetic nephropathy. [ + ]
Avita Medical and BARDA execute a US$24.3m contract option
Regenerative medicine company Avita Medical has announced the execution of an expanded contract option valued at approximately US$24.3 million. [ + ]
Sirtex penalised for alleged continuous disclosure breach
Sirtex Medical has paid a penalty of $100,000 after the Australian Securities and Investments Commission issued an infringement notice for an alleged failure by the company to comply with its continuous disclosure obligations. [ + ]
Deakin University and Chinese biotech company set up lab to develop cancer-detecting blood test
Deakin University and Chinese biotech company Suzhou GenePharma have partnered to develop a blood test that can detect fatal diseases like pancreatic or lung cancer. [ + ]
Paradigm receives ethics approval for osteoarthritis trial
Paradigm Biopharmaceuticals has received ethics approval for its Phase 2b clinical trial to investigate pentosan polysulfate sodium (PPS) in subjects with knee osteoarthritis (OA) and bone marrow edema lesions (BMELs). [ + ]
